STAR randomized 847 US/European patients (3–14 years; -0.50 to -6.00 D) 1:1:1 and demonstrated primary endpoint success at 36 ...

Physiologic AL varies materially with age, sex, height, and ethnicity, undermining fixed AL thresholds as broadly applicable risk stratifiers in typical pediatric myopia. Retinal pathology risk ...

Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical practice. Brianna Rhue, OD, FAAO, co-founder of West Broward Eyecare, discussed ...

Opportunities in the myopia therapeutics market include addressing high prevalence in China, developing FDA-approved treatments beyond atropine sulfate, and leveraging the robust pipeline with assets ...

Please provide your email address to receive an email when new articles are posted on . Patients with high myopia experienced the least thinning in retinal nerve fiber layer. The findings could be ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

In a new consensus report, the National Academies of Sciences, Engineering, and Medicine said that myopia should be classified as a disease that requires a medical diagnosis, and that children should ...

The World Health Organization warns that by 2030, 40% of the world's population will be nearsighted. In the U.S. alone, myopia rates have soared over the past 50 years, from 25% in 1971 to nearly 42% ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The FDA granted a first-ever market authorization for eyeglass lenses for children with myopia, or nearsightedness, the agency announced Thursday. The approval of the Essilor Stellest lenses with ...